224 related articles for article (PubMed ID: 32617865)
1. Evaluation of antifungal activity of cinnamaldehyde against Cryptococcus neoformans var. grubii.
Neelabh ; Singh K
Folia Microbiol (Praha); 2020 Dec; 65(6):973-987. PubMed ID: 32617865
[TBL] [Abstract][Full Text] [Related]
2. Experimental Evolution of Antifungal Resistance in Cryptococcus neoformans.
Bermas A; Geddes-McAlister J
Curr Protoc Microbiol; 2020 Dec; 59(1):e116. PubMed ID: 32986290
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
4. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
Vu K; Gelli A
Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
6. Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.
Nixon GL; McEntee L; Johnson A; Farrington N; Whalley S; Livermore J; Natal C; Washbourn G; Bibby J; Berry N; Lestner J; Truong M; Owen A; Lalloo D; Charles I; Hope W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29311092
[TBL] [Abstract][Full Text] [Related]
7. Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays.
Treviño-Rangel Rde J; Villanueva-Lozano H; Hernández-Rodríguez P; Martínez-Reséndez MF; García-Juárez J; Rodríguez-Rocha H; González GM
Med Mycol; 2016 Mar; 54(3):280-6. PubMed ID: 26705833
[TBL] [Abstract][Full Text] [Related]
8. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
Nascimento E; Vitali LH; Kress MRVZ; Martinez R
Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
11. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
[TBL] [Abstract][Full Text] [Related]
13. A Mechanosensitive Channel Governs Lipid Flippase-Mediated Echinocandin Resistance in Cryptococcus neoformans.
Cao C; Wang Y; Husain S; Soteropoulos P; Xue C
mBio; 2019 Dec; 10(6):. PubMed ID: 31822582
[TBL] [Abstract][Full Text] [Related]
14. In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction.
Rossato L; Loreto ÉS; Venturini TP; Azevedo MI; Weiblen C; Botton SA; Santurio JM; Alves SH
Med Mycol; 2015 Nov; 53(8):885-9. PubMed ID: 26333356
[TBL] [Abstract][Full Text] [Related]
15. Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii.
Khan ZU; Al-Anezi AA; Chandy R; Xu J
J Med Microbiol; 2003 Mar; 52(Pt 3):271-275. PubMed ID: 12621094
[TBL] [Abstract][Full Text] [Related]
16. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
17. Influence of capsule size on the in vitro activity of antifungal agents against clinical Cryptococcus neoformans var. grubii strains.
Vitale RG; Pascuccelli V; Afeltra J
J Med Microbiol; 2012 Mar; 61(Pt 3):384-388. PubMed ID: 22074850
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
[TBL] [Abstract][Full Text] [Related]
19. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
